What NIMH Should Be Doing

Psychiatr Serv. 2022 Mar 1;73(3):247-248. doi: 10.1176/appi.ps.202100620.

Authors

E Fuller Torrey¹, Lisa Dailey¹

Affiliation

¹ Stanley Medical Research Institute, Rockville, Maryland (Torrey); Treatment Advocacy Center, Arlington, Virginia (Dailey).

PMID: 35230869
DOI: 10.1176/appi.ps.202100620

No abstract available

Keywords: Bipolar disorder; Clinical drug studies; National Institute of Mental Health; Schizophrenia; Serious mental illness.

MeSH terms

Bipolar Disorder*
Humans
National Institute of Mental Health (U.S.)
United States